The overall goal of this application is to test the subcellular signaling domains and specific molecular targets for calmodulin kinase II (CaMKII) in heart. Work during the previous funding interval has added significantly to a growing body of evidence showing CaMKII contributes to heart failure and arrhythmias. Studies in this proposal will take advantage of new transgenic mice generated in our laboratory with nuclear and cytoplasmic membrane-targeted CaMKII inhibition. We will also use other mice and dominant-negative constructs to genetically replace CaMKII-targeted residues on key calcium homeostatic proteins. We have evidence that challenges the prevailing paradigm that nuclear CaMKII is preeminent for regulating gene transcription. Our findings suggest CaMKII signaling in cytoplasm crosstalks to the nucleus, and we hypothesize nuclear CaMKII signaling affects excitation contraction coupling and arrhythmias. Experiments to understand if nuclear and/or cytoplasmic CaMKII actions affect for myocyte enhancer factor 2 (MEF2) regulated gene programs will use novel in vivo, cellular and molecular approaches to dissect the effects of CaMKII on MEF2 activity. The following Specific Aims will be used: 1. Test the effects of membrane-targeted and nuclear-targeted CaMKII inhibition on myocardial physiology and as protection against structural heart disease in vivo. 2. Determine the cellular and molecular targets for cytoplasmic CaMKII signaling in cardiomyocyte physiology and disease. 3. Dissect the cellular and molecular signaling pathways for beta adrenergic receptor activation of MEF2 signaling in heart. RELEVENCE. This research is directed toward solving a major public health problem. It is estimated that ~400,000 Americans die annually from sudden cardiac death. Most of these patients have a history of myocardial infarction and heart failure. Targeting these pathways with drugs may reduce suffering in these patients.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL070250-10
Application #
8236900
Study Section
Cardiac Contractility, Hypertrophy, and Failure Study Section (CCHF)
Program Officer
Krull, Holly
Project Start
2002-03-11
Project End
2013-08-14
Budget Start
2012-04-01
Budget End
2013-08-14
Support Year
10
Fiscal Year
2012
Total Cost
$371,250
Indirect Cost
$123,750
Name
University of Iowa
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Unudurthi, Sathya D; Wu, Xiangqiong; Qian, Lan et al. (2016) Two-Pore K+ Channel TREK-1 Regulates Sinoatrial Node Membrane Excitability. J Am Heart Assoc 5:e002865
Manotheepan, Ravinea; Danielsen, Tore K; Sadredini, Mani et al. (2016) Exercise training prevents ventricular tachycardia in CPVT1 due to reduced CaMKII-dependent arrhythmogenic Ca2+ release. Cardiovasc Res 111:295-306
Sommese, Leandro; Valverde, Carlos A; Blanco, Paula et al. (2016) Ryanodine receptor phosphorylation by CaMKII promotes spontaneous Ca(2+) release events in a rodent model of early stage diabetes: The arrhythmogenic substrate. Int J Cardiol 202:394-406
Mesubi, Olurotimi O; Anderson, Mark E (2016) Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal. Cardiovasc Res 109:542-57
Wu, Yuejin; Valdivia, Héctor H; Wehrens, Xander H T et al. (2016) A Single Protein Kinase A or Calmodulin Kinase II Site Does Not Control the Cardiac Pacemaker Ca2+ Clock. Circ Arrhythm Electrophysiol 9:e003180
Gao, Zhan; Sierra, Ana; Zhu, Zhiyong et al. (2016) Loss of ATP-Sensitive Potassium Channel Surface Expression in Heart Failure Underlies Dysregulation of Action Potential Duration and Myocardial Vulnerability to Injury. PLoS One 11:e0151337
Wu, Yuejin; Rasmussen, Tyler P; Koval, Olha M et al. (2015) The mitochondrial uniporter controls fight or flight heart rate increases. Nat Commun 6:6081
Wu, Yuejin; Rasmussen, Tyler P; Koval, Olha M et al. (2015) Corrigendum: The mitochondrial uniporter controls fight or flight heart rate increases. Nat Commun 6:7241
Anderson, Mark E (2015) Oxidant stress promotes disease by activating CaMKII. J Mol Cell Cardiol 89:160-7
Rasmussen, Tyler P; Wu, Yuejin; Joiner, Mei-ling A et al. (2015) Inhibition of MCU forces extramitochondrial adaptations governing physiological and pathological stress responses in heart. Proc Natl Acad Sci U S A 112:9129-34

Showing the most recent 10 out of 125 publications